Analysis of Trunk and Center of Mass Control Development During Gait in Children With Cerebral Palsy (VERTEBRAL)
Analysis of Trunk and Center of Mass Control Development During Gait in Children With Cerebral Palsy
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
270 participants
Sep 20, 2023
OBSERVATIONAL
Conditions
Summary
During the acquisition of posturokinetic abilities such as walking, postural control of the trunk is of paramount importance. Indeed, its development is strongly linked to the overall motor function of children. In cerebral palsy (CP), a term that refers to a set of motor disorders following a perinatal lesion, deficits in axial control are present from early childhood. These deficits are strongly correlated with the functional deficits observed in this population. In particular, during walking, deviations of the trunk (amplitudes, accelerations) are observed in the three planes of space. While recent literature increasingly questions the impact of trunk control deficit on the walking of children with CP, elements are still missing for a holistic understanding of the interaction between locomotor and postural disorders in children with CP. In particular, no study has focused on the deviations of trunk control and the center of mass (which is a global indicator of balance strategies) during the development and maturation of walking in children with CP. Therefore, the primary objective of this cross-sectional observational study will be to characterize the development of trunk control and center of mass during walking in children with CP.
Eligibility
Inclusion Criteria5
- Children (< 18 years) with cerebral palsy
- GMFCS I to III
- Independent walking with or without technical walking aids (walker, crutches, etc.)
- Able to understand the instructions of various clinical assessments and functional explorations
- Affiliated with a social security scheme
Exclusion Criteria7
- Children with cerebral palsy
- Neuro-orthopaedic surgery of the lower limbs or trunk within the last 12 months
- Botulinum toxin A injections within the last 6 months
- Therapeutic intervention targeting trunk control last 6 months
- Typically developing children
- Surgery on lower limbs or trunk last 12 months
- Neurological and/or orthopedic pathology that may influence gait
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06320288